Summit Trail Advisors’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Sell
27,438
-845
-3% -$32K 0.01% 934
2026
Q1
$1.01M Buy
28,283
+1,805
+7% +$65.6K 0.01% 925
2025
Q4
$859K Buy
26,478
+3,975
+18% +$124K 0.01% 893
2025
Q3
$635K Buy
22,503
+4,820
+27% +$138K 0.01% 1008
2025
Q2
$533K Buy
+17,683
New +$599K 0.01% 714
2018
Q1
Sell
-38
Closed -$5K 702
2017
Q4
$5K Buy
+38
New +$3.94K ﹤0.01% 1405

Other funds holding CRI

Summit Trail Advisors's CRI Position: Q2 2026 in Review

Summit Trail Advisors reduced its Carter's (CRI) stake by 3% in Q2 2026, selling an estimated $32K and leaving 27,438 shares worth $1.13M. The position accounts for 0.01% of the portfolio, ranked #934.

Summit Trail Advisors first reported a position in CRI in Q4 2017 and has held it in 6 quarters since. 287 funds tracked by Wall St. Rank hold CRI as of Q2 2026.

  • Summit Trail Advisors held 27,438 shares of Carter's worth $1.13M as of Q2 2026.
  • Summit Trail Advisors sold 845 Carter's shares in Q2 2026, an estimated $32K.
  • Carter's made up 0.01% of Summit Trail Advisors's portfolio in Q2 2026, its #934 holding.
  • Summit Trail Advisors first reported a position in Carter's in Q4 2017 and has held it in 6 quarters since.
  • 287 funds tracked by Wall St. Rank held Carter's as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.